These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27799585)

  • 1. A Clinical Randomized Trial Comparing the Cycloplegic Effect of Cyclopentolate Drops Applied to Closed Eyelids Versus Open Eyelids.
    Zurevinsky J; Sawchuk K; Lim HJ; Lee CH; Rubab S
    Am Orthopt J; 2016 Jan; 66(1):114-121. PubMed ID: 27799585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoscopy in infants using a near noncycloplegic technique, cycloplegia with tropicamide 1%, and cycloplegia with cyclopentolate 1%.
    Twelker JD; Mutti DO
    Optom Vis Sci; 2001 Apr; 78(4):215-22. PubMed ID: 11349929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dilation efficacy: is 1% cyclopentolate enough?
    Hug T; Olitsky S
    Optometry; 2007 Mar; 78(3):119-21. PubMed ID: 17321460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal dosage of cyclopentolate 1% for complete cycloplegia: a randomized clinical trial.
    Bagheri A; Givrad S; Yazdani S; Reza Mohebbi M
    Eur J Ophthalmol; 2007; 17(3):294-300. PubMed ID: 17534806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of drop instillation and spray application of 1% cyclopentolate hydrochloride.
    Ismail EE; Rouse MW; De Land PN
    Optom Vis Sci; 1994 Apr; 71(4):235-41. PubMed ID: 8047334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of objective refraction in darkness to cycloplegic refraction: a pilot study.
    Vasudevan B; Ciuffreda KJ; Meehan K; Grk D; Cox M
    Clin Exp Optom; 2016 Mar; 99(2):168-72. PubMed ID: 26888570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cycloplegia at 20- and 30-minutes following proxymetacaine and cyclopentolate instillation in white 12-13-year-olds.
    Doyle M; O' Dwyer V; Harrington S
    Clin Exp Optom; 2023 Nov; 106(8):890-895. PubMed ID: 36750050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cycloplegic Refraction in Hyperopic Children: Effectiveness of a 0.5% Tropicamide and 0.5% Phenylephrine Addition to 1% Cyclopentolate Regimen.
    Yoo SG; Cho MJ; Kim US; Baek SH
    Korean J Ophthalmol; 2017 Jun; 31(3):249-256. PubMed ID: 28471102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized clinical trial using atropine, cyclopentolate, and tropicamide to compare refractive outcome in hypermetropic children with a dark iris; skin pigmentation and crying as significant factors for hypermetropic outcome.
    van Minderhout HM; Joosse MV; Grootendorst DC; Schalij-Delfos NE
    Strabismus; 2019 Sep; 27(3):127-138. PubMed ID: 31234691
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors Affecting Pupil Reactivity After Cycloplegia in Asian Children.
    Lim J; Chia A; Saffari SE; Handa S
    Asia Pac J Ophthalmol (Phila); 2019; 8(4):304-307. PubMed ID: 31385819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized clinical trial using cyclopentolate and tropicamide to compare cycloplegic refraction in Chinese young adults with dark irises.
    Pei R; Liu Z; Rong H; Zhao L; Du B; Jin N; Zhang H; Wang B; Pang Y; Wei R
    BMC Ophthalmol; 2021 Jun; 21(1):256. PubMed ID: 34112149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a Cycloplegic Agent Administered as a Spray in the Pediatric Population.
    Vagge A; Del Noce C; Pellegrini M; Cappelli F; Musolino M; Bernabei F; Giannaccare G; Traverso CE
    J Pediatr Ophthalmol Strabismus; 2020 Sep; 57(5):301-304. PubMed ID: 32956479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cycloplegia in African-American children.
    Kleinstein RN; Mutti DO; Manny RE; Shin JA; Zadnik K
    Optom Vis Sci; 1999 Feb; 76(2):102-7. PubMed ID: 10082056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Cyclopentolate on Ocular Biometric Components.
    Hashemi H; Asharlous A; Khabazkhoob M; Iribarren R; Khosravi A; Yekta A; Emamian MH; Fotouhi A
    Optom Vis Sci; 2020 Jun; 97(6):440-447. PubMed ID: 32511166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cycloplegia on the refractive status of children: the Shandong children eye study.
    Hu YY; Wu JF; Lu TL; Wu H; Sun W; Wang XR; Bi HS; Jonas JB
    PLoS One; 2015; 10(2):e0117482. PubMed ID: 25658329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onset and duration of cycloplegic action of 1% cyclopentolate - 1% tropicamide combination.
    Kyei S; Nketsiah AA; Asiedu K; Awuah A; Owusu-Ansah A
    Afr Health Sci; 2017 Sep; 17(3):923-932. PubMed ID: 29085421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of cycloplegic agents: results of a randomized controlled trial in nigerian children.
    Ebri A; Kuper H; Wedner S
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1025-31. PubMed ID: 17325142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of cyclopentolate drops versus spray in cycloplegia in children].
    Chafai A; Ajdnik S; Lejeune L; Cordonnier M
    J Fr Ophtalmol; 2006 Oct; 29(8):896-9. PubMed ID: 17075505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective comparison between cyclopentolate spray and drops in pediatric outpatients.
    Syrimi M; Jones SM; Thompson GM
    J Pediatr Ophthalmol Strabismus; 2013; 50(5):290-5. PubMed ID: 23705592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tropicamide Versus Cyclopentolate for Cycloplegic Refraction in Pediatric Patients With Brown Irides: A Randomized Clinical Trial.
    Al-Thawabieh W; Al-Omari R; Abu-Hassan DW; Abuawwad MT; Al-Awadhi A; Abu Serhan H
    Am J Ophthalmol; 2024 Jan; 257():218-226. PubMed ID: 37797867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.